sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease

Abstract Microglial activation occurs early in Alzheimer's disease (AD) and previous studies reported both detrimental and protective effects of microglia on AD progression. Here, we used CSF sTREM2 to investigate disease stage‐dependent drivers of microglial activation and to determine downstr...

Full description

Saved in:
Bibliographic Details
Main Authors: Davina Biel, Marc Suárez‐Calvet, Paul Hager, Anna Rubinski, Anna Dewenter, Anna Steward, Sebastian Roemer, Michael Ewers, Christian Haass, Matthias Brendel, Nicolai Franzmeier, for the Alzheimer's Disease Neuroimaging Initiative (ADNI)
Format: Article
Language:English
Published: Springer Nature 2023-01-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.15252/emmm.202216987
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849226103006167040
author Davina Biel
Marc Suárez‐Calvet
Paul Hager
Anna Rubinski
Anna Dewenter
Anna Steward
Sebastian Roemer
Michael Ewers
Christian Haass
Matthias Brendel
Nicolai Franzmeier
for the Alzheimer's Disease Neuroimaging Initiative (ADNI)
author_facet Davina Biel
Marc Suárez‐Calvet
Paul Hager
Anna Rubinski
Anna Dewenter
Anna Steward
Sebastian Roemer
Michael Ewers
Christian Haass
Matthias Brendel
Nicolai Franzmeier
for the Alzheimer's Disease Neuroimaging Initiative (ADNI)
author_sort Davina Biel
collection DOAJ
description Abstract Microglial activation occurs early in Alzheimer's disease (AD) and previous studies reported both detrimental and protective effects of microglia on AD progression. Here, we used CSF sTREM2 to investigate disease stage‐dependent drivers of microglial activation and to determine downstream consequences on AD progression. We included 402 patients with measures of earliest beta‐amyloid (CSF Aβ1‐42) and late‐stage fibrillary Aβ pathology (amyloid‐PET centiloid), as well as sTREM2, p‐tau181, and FDG‐PET. To determine disease stage, we stratified participants into early Aβ‐accumulators (Aβ CSF+/PET−; n = 70) or late Aβ‐accumulators (Aβ CSF+/PET+; n = 201) plus 131 controls. In early Aβ‐accumulators, higher centiloid was associated with cross‐sectional/longitudinal sTREM2 and p‐tau181 increases. Further, higher sTREM2 mediated the association between centiloid and cross‐sectional/longitudinal p‐tau181 increases and higher sTREM2 was associated with FDG‐PET hypermetabolism. In late Aβ‐accumulators, we found no association between centiloid and sTREM2 but a cross‐sectional association between higher sTREM2, higher p‐tau181 and glucose hypometabolism. Our findings suggest that a TREM2‐related microglial response follows earliest Aβ fibrillization, manifests in inflammatory glucose hypermetabolism and may facilitate subsequent p‐tau181 increases in earliest AD.
format Article
id doaj-art-ea66371c81c9496c92efbf79d69b23c9
institution Kabale University
issn 1757-4676
1757-4684
language English
publishDate 2023-01-01
publisher Springer Nature
record_format Article
series EMBO Molecular Medicine
spelling doaj-art-ea66371c81c9496c92efbf79d69b23c92025-08-24T11:43:47ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842023-01-0115211310.15252/emmm.202216987sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's diseaseDavina Biel0Marc Suárez‐Calvet1Paul Hager2Anna Rubinski3Anna Dewenter4Anna Steward5Sebastian Roemer6Michael Ewers7Christian Haass8Matthias Brendel9Nicolai Franzmeier10for the Alzheimer's Disease Neuroimaging Initiative (ADNI)Institute for Stroke and Dementia Research (ISD), University Hospital, LMU MunichBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall FoundationInstitute of Radiology and Artificial Intelligence and Informatics in Medicine, TU MunichInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU MunichInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU MunichInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU MunichInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU MunichInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU MunichGerman Center for Neurodegenerative Diseases (DZNE)German Center for Neurodegenerative Diseases (DZNE)Institute for Stroke and Dementia Research (ISD), University Hospital, LMU MunichAbstract Microglial activation occurs early in Alzheimer's disease (AD) and previous studies reported both detrimental and protective effects of microglia on AD progression. Here, we used CSF sTREM2 to investigate disease stage‐dependent drivers of microglial activation and to determine downstream consequences on AD progression. We included 402 patients with measures of earliest beta‐amyloid (CSF Aβ1‐42) and late‐stage fibrillary Aβ pathology (amyloid‐PET centiloid), as well as sTREM2, p‐tau181, and FDG‐PET. To determine disease stage, we stratified participants into early Aβ‐accumulators (Aβ CSF+/PET−; n = 70) or late Aβ‐accumulators (Aβ CSF+/PET+; n = 201) plus 131 controls. In early Aβ‐accumulators, higher centiloid was associated with cross‐sectional/longitudinal sTREM2 and p‐tau181 increases. Further, higher sTREM2 mediated the association between centiloid and cross‐sectional/longitudinal p‐tau181 increases and higher sTREM2 was associated with FDG‐PET hypermetabolism. In late Aβ‐accumulators, we found no association between centiloid and sTREM2 but a cross‐sectional association between higher sTREM2, higher p‐tau181 and glucose hypometabolism. Our findings suggest that a TREM2‐related microglial response follows earliest Aβ fibrillization, manifests in inflammatory glucose hypermetabolism and may facilitate subsequent p‐tau181 increases in earliest AD.https://doi.org/10.15252/emmm.202216987Alzheimer's diseasebeta‐amyloidglucose metabolismp‐tausTREM2
spellingShingle Davina Biel
Marc Suárez‐Calvet
Paul Hager
Anna Rubinski
Anna Dewenter
Anna Steward
Sebastian Roemer
Michael Ewers
Christian Haass
Matthias Brendel
Nicolai Franzmeier
for the Alzheimer's Disease Neuroimaging Initiative (ADNI)
sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease
EMBO Molecular Medicine
Alzheimer's disease
beta‐amyloid
glucose metabolism
p‐tau
sTREM2
title sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease
title_full sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease
title_fullStr sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease
title_full_unstemmed sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease
title_short sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease
title_sort strem2 is associated with amyloid related p tau increases and glucose hypermetabolism in alzheimer s disease
topic Alzheimer's disease
beta‐amyloid
glucose metabolism
p‐tau
sTREM2
url https://doi.org/10.15252/emmm.202216987
work_keys_str_mv AT davinabiel strem2isassociatedwithamyloidrelatedptauincreasesandglucosehypermetabolisminalzheimersdisease
AT marcsuarezcalvet strem2isassociatedwithamyloidrelatedptauincreasesandglucosehypermetabolisminalzheimersdisease
AT paulhager strem2isassociatedwithamyloidrelatedptauincreasesandglucosehypermetabolisminalzheimersdisease
AT annarubinski strem2isassociatedwithamyloidrelatedptauincreasesandglucosehypermetabolisminalzheimersdisease
AT annadewenter strem2isassociatedwithamyloidrelatedptauincreasesandglucosehypermetabolisminalzheimersdisease
AT annasteward strem2isassociatedwithamyloidrelatedptauincreasesandglucosehypermetabolisminalzheimersdisease
AT sebastianroemer strem2isassociatedwithamyloidrelatedptauincreasesandglucosehypermetabolisminalzheimersdisease
AT michaelewers strem2isassociatedwithamyloidrelatedptauincreasesandglucosehypermetabolisminalzheimersdisease
AT christianhaass strem2isassociatedwithamyloidrelatedptauincreasesandglucosehypermetabolisminalzheimersdisease
AT matthiasbrendel strem2isassociatedwithamyloidrelatedptauincreasesandglucosehypermetabolisminalzheimersdisease
AT nicolaifranzmeier strem2isassociatedwithamyloidrelatedptauincreasesandglucosehypermetabolisminalzheimersdisease
AT forthealzheimersdiseaseneuroimaginginitiativeadni strem2isassociatedwithamyloidrelatedptauincreasesandglucosehypermetabolisminalzheimersdisease